subject: Aeterna Zentaris Inc. (aez) Swot Profile---aarkstore Enterprise Market Research Aggregation [print this page] Summary Summary
AEterna Zentaris Inc. (AEZ) SWOT Profile is a comprehensive business, functional and strategic analysis of AEterna Zentaris Inc.. The profile delves into the operations of the company to present an in-depth analysis of the various aspects related to its business. It analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, executive biographies and key competitors. The hallmark of the profile is the detailed strategic analysis of the company. This highlights and presents an unbiased view of its key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by understanding your partners, customers and competitors better.
AEterna Zentaris Inc. (AEterna Zentaris) is a late-stage drug development company engaged in the development of therapeutics for the treatment of cancer, endocrine disorders and infectious diseases. Its key product is Cetrotide, the first luteinizing hormone-releasing hormone (LHRH) antagonist treatment approved for in-vitro fertilization. The company carries out its operations in Canada, the US and Europe. It is headquartered in Quebec, Canada.
Apr 05, 2010: FDA Grants Fast Track Designation To Keryx Biopharmaceuticals Perifosine
Mar 25, 2010: terna Zentaris Q4 Revenues Surges
Scope
- Examines key information about company for business intelligence.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented objectively. Business, strategic and operational aspects are taken into account.
- Opportunities available to the company are sized up and its growth potential assessed. Competitive and/or technological threats are highlighted.
- The profile contains valuable and critical company information business structure and operations, the company history, major products and services, prospects, key competitors, key employees, executive biographies, important locations and subsidiaries.
- The profile provides detailed financial ratios for the past five years as well as interim ratios for the last five interim periods for major public companies.
- Financial ratios presented for major public companies include revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
